Highlights

  • Wesfarmers (ASX: WES) closed at AUD 88.11 on 23 July 2026, falling 1.99% or AUD 1.79.
  • The stock underperformed the S&P/ASX 200, which gained 0.18% or 16 points to close at 8,839.00.
  • Wesfarmers and SQM have approved a $1.4 billion expansion of the Mount Holland lithium operation.
  • The project aims to double spodumene concentrate production to 760,000 tonnes annually and lower unit operating costs.
  • Additional mine output cannot yet be fully processed at the Covalent refinery, which requires a separate expansion.

Wesfarmers Limited (ASX:WES) closed lower on 23 July 2026 as investors continued assessing its sizeable counter-cyclical investment in lithium.

The stock ended the session at AUD 88.11, declining 1.99% or AUD 1.79. This contrasted with the broader S&P/ASX 200, which gained 0.18% to finish at 8,839.00.

The fall came after Wesfarmers and Chilean lithium producer SQM approved a $1.4 billion expansion of their Mount Holland lithium operation in Western Australia. The investment is intended to double spodumene concentrate production and position the joint venture for a potential recovery in lithium demand and pricing.

However, the share-price reaction showed that investors remain cautious about committing substantial capital to a commodity that has recently experienced significant price volatility.

What Have Wesfarmers and SQM Approved?

Wesfarmers and SQM have approved a $1.4 billion expansion of the Mount Holland lithium mine, with each partner expected to contribute up to $715 million.

The expansion is designed to lift annual spodumene concentrate production to approximately 760,000 tonnes, effectively doubling existing capacity.

A new ore-sorting facility will also be constructed as part of the project. Ore sorting is intended to separate higher-grade material from waste earlier in the production process, potentially improving processing efficiency and reducing unit operating costs.

Wesfarmers has indicated that the project should support lower costs and higher cash flow over time, although those outcomes depend on successful construction, ramp-up and lithium pricing.

Why Did Wesfarmers Shares Fall 1.99%?

Wesfarmers’ decline suggested the market remained cautious about the scale, timing and risk profile of the lithium investment.

The stock fell 1.99%, while the S&P/ASX 200 rose 0.18%, resulting in underperformance of 2.17 percentage points.

The move was larger than the earlier intraday decline discussed in the original article, showing that selling pressure continued through the session.

Investor concerns may centre on the amount of capital being directed towards a cyclical commodity after a period of weak lithium prices. The project also carries construction and execution risks, while the full benefit depends partly on a future expansion of the Covalent lithium refinery.

The decline does not necessarily indicate that investors reject the strategy. Instead, it may reflect uncertainty about how quickly the investment can produce returns.

Mount Holland Targets a Major Production Increase

The central objective of the expansion is to double spodumene concentrate output to 760,000 tonnes per year.

Higher production would give the joint venture greater exposure to any sustained recovery in lithium prices. It may also allow fixed costs to be spread across more tonnes, improving unit economics if the operation performs as expected.

The planned ore-sorting facility is particularly important to the cost-reduction strategy. By removing lower-grade waste earlier, the operation may reduce the volume of material passing through more expensive processing stages.

For Wesfarmers, the investment is therefore not only about producing more lithium. It is also aimed at making the operation more efficient and competitive through the commodity cycle.

The Covalent Refinery Remains a Bottleneck

An important limitation is that the additional spodumene concentrate cannot yet be fully processed at the Covalent lithium refinery near Perth.

The refinery converts spodumene concentrate into higher-value lithium chemicals used in battery manufacturing. However, its current capacity is insufficient to handle the additional output planned from Mount Holland.

A separate refinery expansion will therefore be required before the joint venture can process the entire increase in concentrate production into refined lithium products.

This creates a sequencing risk. The mine expansion may lift upstream output before the downstream facility is ready, potentially delaying the full economic benefit of the integrated operation.

Investors will likely monitor the cost, timing and approval process for the refinery expansion closely.

Why Wesfarmers Is Investing During a Downturn

The Mount Holland expansion represents a counter-cyclical investment strategy.

Lithium prices had fallen sharply from previous highs, placing pressure on higher-cost producers and forcing some operations to reduce output or close. Wesfarmers and SQM appear to be using the downturn to invest in capacity and operating efficiency before a possible recovery.

This strategy can be attractive if the project is completed while construction demand and asset costs are more manageable, and if lithium prices recover as additional production becomes available.

However, timing commodity cycles is difficult. A prolonged period of weak lithium pricing could delay returns and test the economics of the expansion.

The success of the investment therefore depends on both operational execution and the broader lithium-market recovery.

Wesfarmers’ Broader Business Provides Support

Wesfarmers is a diversified conglomerate with substantial retail and industrial operations.

Its portfolio includes businesses such as Bunnings and Kmart, alongside chemicals, energy and lithium interests. This diversification means the company is not solely dependent on Mount Holland or the lithium price.

Cash flow from established retail operations may provide financial capacity to fund longer-term growth projects through weaker commodity cycles.

At the same time, the lithium investment introduces greater exposure to commodity volatility and project risk within a group often valued for relatively predictable retail earnings.

This balance between stable businesses and cyclical growth assets will remain an important consideration for shareholders.

Potential Benefits of the Expansion

The first potential benefit is higher production. Doubling output could materially increase the volume available for sale if lithium demand and pricing improve.

The second is lower unit costs. The ore-sorting facility and greater operating scale may improve efficiency and strengthen the operation’s position on the global cost curve.

The third is downstream potential. Once the Covalent refinery is expanded, a larger portion of output could be converted into higher-value lithium chemicals.

The fourth is strategic positioning. Mount Holland could give Wesfarmers greater exposure to long-term battery and energy-storage demand.

These potential benefits remain dependent on execution, market conditions and the timing of the refinery expansion.

Principal Risks and Uncertainties

Lithium-price volatility is the most significant risk.

If prices remain weak or decline further, the financial returns from the expansion may be lower than expected. The project also carries the usual risks associated with large mining developments, including construction delays, cost overruns and ramp-up challenges.

The Covalent refinery requirement creates additional uncertainty because the mine and refinery expansions must be coordinated to maximise value.

Demand for lithium may also be affected by electric-vehicle adoption, battery technology, government policy and global economic conditions.

Capital allocation is another consideration. Investors may question whether committing up to $715 million is the best use of Wesfarmers’ funds if lithium-market conditions remain uncertain.

What Investors May Watch Next

The lithium price will remain one of the most important indicators for the investment case.

Investors will also monitor construction progress at Mount Holland, development of the ore-sorting facility and whether projected cost reductions are achieved.

A formal decision on expanding the Covalent refinery will be another major checkpoint. The timing and cost of that project will help determine when the additional concentrate can be converted into refined lithium products.

Wesfarmers’ future financial updates may also provide greater detail on capital expenditure, project timing and expected returns from the joint venture.

Conclusion

Wesfarmers (ASX: WES) closed at AUD 88.11 on 23 July 2026, declining 1.99% or AUD 1.79. The stock underperformed the S&P/ASX 200, which gained 0.18% to close at 8,839.00.

The weaker share-price performance reflected investor caution following the approval of a $1.4 billion Mount Holland lithium expansion with SQM.

The project offers the potential for higher production, lower unit costs and stronger exposure to a future lithium recovery. However, its success depends on commodity prices, construction execution and a separate expansion of the Covalent refinery.

The investment is a calculated counter-cyclical move rather than a guaranteed indicator that the lithium downturn has ended. The coming stages of construction, refinery planning and market pricing will determine whether Wesfarmers’ conviction is rewarded.